Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Cisplatin 32Paclitaxel 29Radiotherapy 21Fluorouracil 20Radiation 12camrelizumab 11Oxaliplatin 11Docetaxel 11Carboplatin 10Capecitabine 9Esophagectomy 8Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 6Leucovorin 6Endoscopic Mucosal Resection 6Drug Therapy 6apatinib 5Neoadjuvant Therapy 5Chemoradiotherapy 5nedaplatin 4S 1 (combination) 4Preoperative Exercise 4Irinotecan 4Endoscopy 4Cetuximab 4Albumin-Bound Paclitaxel 4pembrolizumab 3TP protocol 3Radiotherapy, Adjuvant 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Esophageal Neoplasms × enoxaparin sodium × Clear all
NCT03254511 2017-08-22

Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Mashhad University of Medical Sciences

Phase 2 Unknown
100 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡